BT_edit_final.qxp 25/6/09 02:56 Page 46
Bibliography
1. Hughes B, 2008 FDA drug approvals, Nat Rev Drug Discov, 19. PwC, The changing dynamics of pharma outsourcing in Asia: Are
2009;8:93–96. you readjusting your sights?, 2008.
2. BNP press release, 9 August 2007. See
invest.bnpparibas.com for 20. PwC, Pharma 2020: The vision. Which path will you take?
official statement. 21. Powell B, Heparin’s Deadly Side Effects, Time, 13 November 2008.
3. BBC, Timeline: Credit crunch to downturn. Available at: 22. Klappich CD, Top 7 Supply Chain Execution Processes, 2009 to
news.bbc.co.uk/1/hi/business/7521250.stm (accessed 8 June 2014, Gartner, 17 March 2009
2009). 23. Kager P, Williams D, How do you solve a problem like
4. Roche Plans to Cut 780 Jobs, Wall Street Journal, 15 January manufacturing?, Pharmaceutical Executive, 1 September 2008.
2009. 24. NICE, Press Release, 24 October 2007 (accessed 8 June 2009).
5. Arlington S, Evans T, Market Insight – Billion dollar maybe, Scrip 25. Central Massachusetts Independent Physician Association, P4P,
World Pharmaceutical News, 5 February 2009. 23 September 2005.
6. BBC, From biggest carmaker to biggest bankruptcy. Available at: 26. Kanavos P, Costa-i-Font J, Merkur S, Gemmill M, The Economic
news.bbc.co.uk/1/hi/business/8068434.stm (accessed 8 June Impact of Pharmaceutical Parallel Trade in European Union
2009). Member States: A Stakeholder Analysis, London School of
7. BBC, Q&A: What next for Chrysler? Available at: Economics and Political Science, 2004.
news.bbc.co.uk/1/hi/business/8028113.stm 27. Cockburn R, Newton PN, Agyarko EK, et al., The Global Threat of
8. Wikipedia, Automotive industry crisis of 2008–2009. Available at: Counterfeit Drugs: Why Industry and Governments Must
en.wikipedia.org/wiki/Automotive_industry_crisis_of_2008-2009 Communicate the Dangers, PLoS Medicine, 2005;2(4):e100.
(accessed 8 June 2009). 28. Pharmaceutical Executive Europe, Putting an End to Drug
9. Cancer patient genome sequenced for the first time, Counterfeiting, 2008.
Physorg.com, 5 November 2008. 29. FDA, Guidance for industry: PAT – A framework for innovative
10. Bush C, Sustainable Sourcing: A New Approach to High pharmaceutical development, manufacturing and quality
Performance in Supply Chain Management, Accenture, 2008. assurance, 2004.
11.
ICIS.com, Pharma firms bolster pipeline with biologics: Pharma 30. Wikoff D, Use lean manufacturing principles to deliver green
taps biologics, 26 September 2008 (accessed 8 June 2009). results, Reliable Plant Magazine, 2009
12. Datamonitor, Biologics will be a key driver of growth for the 31. Glatzel C, Helmcke S, Wine J, Building a flexible supply chain for
pharmaceutical industry, 2006. uncertain times, The McKinsey Quarterly, March 2003.
13. Frost & Sullivan, Use of Therapeutic Monoclonal Antibodies 32. IBM, Pharma 2010: The value-creating supply chain.
Increasing in Europe, 2008. 33. FDA docket. Available at:
www.fda.gov/oc/guidance/
14. Datamonitor, M&A Trends in Pharma, October 2008. drugsupplychain.html
15. Arnst C, Lilly’s Risky Rush into Cancer Drugs, Business Week, 20 34. Pellek A, Drug Serialization and Supply-Chain Security,
October 2008. Pharmaceutical Technology, Volume 33, Issue 6
16. Bryan L, Farrell D, Leading through uncertainty, The McKinsey 35. McGory J, Curing the Pharmaceutical Supply Chain, Next
Quarterly, December 2008. Generation Pharmaceutical.
17. Kalorama, World Market for Prescription Generic Drugs, 6th 36. Mannings R, Ubiquitous Positioning, Artech House, Norwood,
Edition, 2008. MA, 2008.
18. Engardio P, Weintraub A, Outsourcing the Drug Industry, Business 37. Stackpole B, Pharma Gears up for a Supply Chain Overhaul,
Week, 15 September 2008. Managing Automation, June 2008.
46
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51